The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

CMS’ decision to phase out the Medicare Inpatient Only list in 2026 marks a consequential site-of-service policy that could rapidly accelerate the migration of complex procedures to outpatient ...

The Centers for Medicare & Medicaid Services (CMS) released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. Designed to limit ...

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...

Bipartisan efforts to lower prescription drug costs remains a core focus for the US Congress. Effective October 1, 2024, the Centers for Medicare and Medicaid Services (CMS) has announced the ...

The Medicare Inpatient Only (IPO) list details the procedures that Medicare will cover in an inpatient setting. The Centers for Medicare & Medicaid Services (CMS) releases the IPO list each year. The ...

CMS published a list of generic drugs to be included under its proposed Medicare $2 Drug List Model Oct. 9. 1. Under the model, individuals enrolled in participating Medicare Part D plans would pay no ...

The U.S. government has announced significant Medicare drug price cuts affecting 15 major drugs, with Novo Nordisk appearing most impacted by the latest round. Despite headline-grabbing price ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 ...